Abiopharma

News list

Director Shotwell Gwynne 🟢 acquired 2.6K shares of Polaris Inc. (PII) at $66.27 Transaction Date: Apr 30, 2026 | Filing ID: 029424

Full text

News bot May 1, 2026, 9:10 p.m.
🔍 Shotwell Gwynne (Director)

Company: Polaris Inc. (PII)

Report Date: 2026-04-30
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 2,641
Detailed Transactions and Holdings:
- Acquired 2,641 shares of Common Stock at $66.27 per share (Direct)
  Date: 2026-04-30 | Code: A | equity_swap_involved: 0 | shares_owned_after: 28,715.42 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: The reported transaction involved the crediting of 2,641 deferred stock units granted under the Amended & Restated Polaris Inc. 2024 Omnibus Incentive Plan, each of which may be settled in one share of common stock pursuant to the Company's Deferred Compensation Plan for Directors.